Lancer Orthodontics, Inc.

LANZ · OTC
Analyze with AI
8/31/2004
5/31/2004
2/29/2004
11/30/2003
Valuation
PEG Ratio0.050.110.00-0.93
FCF Yield-9.15%-2.27%-10.51%-3.95%
EV / EBITDA-32.6016.6517.59105.98
Quality
ROIC2.38%-1.62%1.77%0.06%
Gross Margin27.58%39.92%29.89%29.66%
Cash Conversion Ratio1.830.42-0.974.73
Growth
Revenue 3-Year CAGR1.75%0.01%-0.49%-1.59%
Free Cash Flow Growth-353.78%74.25%-150.09%72.43%
Safety
Net Debt / EBITDA2.29-3.57-0.93-18.12
Interest Coverage0.00-55.3289.296.43
Efficiency
Inventory Turnover0.530.490.660.63
Cash Conversion Cycle206.80217.44175.00175.93